REMEDITEX VENTURES
Remeditex was formed to invest in high quality, innovative, early stage projects that are judged to have commercialization potential. The goal is to help investigators establish the commercial viability of their research making it attractive to traditional investors.
REMEDITEX VENTURES
Industry:
Biotechnology Health Care Venture Capital
Founded:
2011-05-12
Status:
Active
Contact:
(214) 506-2662
Email Addresses:
[email protected]
Technology used in webpage:
SPF Euro Microsoft Exchange Online Amazon Office 365 Mail GoDaddy DNS Amazon Virginia Region
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Polaris Partners
Polaris Partners is an investment firm that invests in healthcare and biotechnology companies.
Roche Venture Fund
The Roche Venture Fund is the name given to the corporate venture fund of the healthcare company Roche.
Current Advisors List
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-06-17 | Soliton | Remeditex Ventures investment in Post-IPO Equity - Soliton | 9.45 M USD |
| 2017-09-18 | Rodin Therapeutics | Remeditex Ventures investment in Series C - Rodin Therapeutics | 27 M USD |
| 2017-07-18 | VYNE Therapeutics | Remeditex Ventures investment in Series C - VYNE Therapeutics | 50.5 M USD |
| 2016-09-15 | Peloton Therapeutics | Remeditex Ventures investment in Series D - Peloton Therapeutics | 52.4 M USD |
| 2015-12-18 | Navitor Pharmaceuticals | Remeditex Ventures investment in Series B - Navitor Pharmaceuticals | 33 M USD |
| 2015-11-10 | Viridian Therapeutics | Remeditex Ventures investment in Series C - Viridian Therapeutics | 40.7 M USD |
| 2015-11-01 | VYNE Therapeutics | Remeditex Ventures investment in Series B - VYNE Therapeutics | 45 M USD |
| 2015-05-01 | VYNE Therapeutics | Remeditex Ventures investment in Series A - VYNE Therapeutics | 14.3 M USD |
| 2015-02-18 | Viridian Therapeutics | Remeditex Ventures investment in Series B - Viridian Therapeutics | 8.5 M USD |
| 2014-06-27 | Viridian Therapeutics | Remeditex Ventures investment in Series B - Viridian Therapeutics | 7 M USD |
More informations about "Remeditex Ventures"
Remeditex Ventures - Crunchbase Investor Profile & Investments
The goal is to help investigators establish the commercial viability of their research making it attractive to traditional investors. Remeditex was formed to invest in high quality, innovative, …See details»
Remeditex Ventures investment portfolio - PitchBook
Information on investments, active portfolio, exits, fund performance, dry powder, and co-investors for Remeditex Ventures. Use the PitchBook Platform to explore the full profile.See details»
Remeditex Ventures - Investments, Portfolio & Company Exits
Remeditex was formed to invest in high quality, innovative, early stage projects that are judged to have commercialization potential.See details»
REMEDITEX VENTURES LLC Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for REMEDITEX VENTURES LLC of Dallas, TX. Get the latest business insights from Dun & Bradstreet.See details»
Home - Lyda Hill Philanthropies
In 2011, Lyda Hill launched a $200 million biotechnology venture fund, Remeditex Ventures. The fund invested in promising early-stage life science technologies spinning out of North Texas …See details»
Remeditex Ventures LLC - Company Profile and News
Remeditex Ventures LLC operates as a venture capital firm. The Company invests in life sciences, therapeutics technologies, pharmacy, biomedical science, diagnostics, and …See details»
Investments - Lyda Hill Philanthropies
In 2011, Lyda Hill launched a $200 million biotechnology venture fund, Remeditex Ventures. The fund invested in promising early-stage life science technologies spinning out of Texas medical …See details»
Remeditex Ventures - CB Insights
Nov 18, 2019 · Remeditex Ventures provides the business and scientific discipline to translate promising scientific discovery into the marketplace to improve health and well-being while …See details»
Remeditex Ventures - Contacts, Employees, Board Members
Remeditex Ventures has 4 current employee profiles, including President Brett Ringle. Remeditex Ventures has 3 board members and advisors, including Colleen McHugh.See details»
Remeditex Ventures - Massinvestor Venture Capital and Private …
Remeditex Ventures' mission is to develop early stage biomedical science and make Texas a preferred location for biotechnology companies, venture capitalists, and entrepreneurs.See details»
Velocity Pharmaceutical Development and Remeditex Ventures …
Aug 19, 2013 · Under this agreement, VPD and Remeditex will jointly evaluate pharmaceutical development opportunities for management by the VPD development team and potential …See details»
Soliton Announces $6.25 Million Private Placement - PR Newswire
Oct 10, 2019 · The financing was led by Remeditex Ventures, LLC, the Company's largest shareholder, which agreed to purchase $2.0 million of the securities in the private placement.See details»
Remeditex Ventures - Tech Stack, Apps, Patents & Trademarks
Nov 10, 2024 · Remeditex was formed to invest in high quality, innovative, early stage projects that are judged to have commercialization potential.See details»
BionorthTX Names Pharma Entrepreneur, Investor, and …
Sep 9, 2019 · North Texas has a booming biotech sector that includes Fort Worth businessman Paul Dorman, the chairman and CEO of DFB Pharmaceuticals who has a strong record as an …See details»
Viet Dao - Xã Mễ Trì, Hanoi, Vietnam | Professional Profile - LinkedIn
MSc Finance, Newcastle University Business School · To further connect please send me an email at [email protected] · Experience: KPMG Vietnam · Education: Newcastle …See details»
Xã Mễ Trì Map - Locality - Hanoi, Vietnam - Mapcarta
Xã Mễ Trì Xã Mễ Trì is a locality in Hanoi, Northern Vietnam.Xã Mễ Trì is situated nearby to the quarter Phu Do, as well as near the locality Đinh Thôn.See details»
John Creecy - Chief Executive Officer & Director @ Remeditex …
John Creecy is the Chief Executive Officer & Director at Remeditex Ventures. Additionally, John Creecy has had 2 past jobs including Chief Operating Officer & Chief Financial Officer at The …See details»
Hanoi - KPMG Vietnam
For more detail about the structure of the KPMG global organization please visit https://kpmg.com/governance.See details»
Cốm Mễ Trì Hoà Hà - Facebook
Cốm Mễ Trì Hoà Hà. 1,488 likes · 1 talking about this. Cơ sở sản xuất Cốm Mễ Trì Hoà Hà • Cốm tươi - cốm khô - xôi cốm - chả cốm - xúc xích cốm- bánh...See details»
Dennis Keith Stone - CSO @ Remeditex Ventures - Crunchbase
Dennis is Chief Scientific Officer and a Director of Remeditex Ventures LLC. He joined Remeditex in August 2011 from UT Southwestern Medical Center, or UTSW, where he was Professor of …See details»